Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 3/20 | 0.56 |
| ▸ | RAB9A | P51151 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | JMJD6 | Q6NYC1 | 1/20 | 0.49 |
| ▸ | MMP9 | P14780 | 2/20 | 0.49 |
| ▸ | MMP12 | P39900 | 2/20 | 0.49 |
| ▸ | MMP1 | P03956 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | MMP2 | P08253 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | STS | P08842 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | ESR1 | P03372 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31205812 | 1.00 | NPC1 (0.56) | NPC1RAB9AKMT2AL3MBTL1JMJD6 | |
| SCHEMBL20285817 | 1.00 | NPC1 (0.56) | NPC1RAB9AKMT2AL3MBTL1JMJD6 | |
| SCHEMBL31205426 | 1.00 | NPC1 (0.56) | NPC1RAB9AKMT2AL3MBTL1JMJD6 | |
| SCHEMBL18304685 | 0.98 | NPC1 (0.54) | NPC1RAB9AKMT2AL3MBTL1JMJD6 | |
| SCHEMBL31205637 | 0.98 | NPC1 (0.54) | NPC1RAB9AKMT2AL3MBTL1JMJD6 | |
| SCHEMBL27918862 | 0.95 | KMT2A (0.51) | NPC1RAB9AKMT2AL3MBTL1JMJD6 | |
| Cyclohexanol SCHEMBL18304689 | 0.94 | NPC1 (0.51) | NPC1RAB9AKMT2AL3MBTL1JMJD6 | |
| SCHEMBL16502289 | 0.92 | KMT2A (0.54) | NPC1RAB9AKMT2ASMN1; SMN2POLB | |
| SCHEMBL111296 | 0.89 | MMP9 (0.55) | NPC1RAB9AKMT2AL3MBTL1JMJD6 | |
| SCHEMBL18304691 | 0.86 | NPC1 (0.47) | NPC1RAB9AKMT2AL3MBTL1JMJD6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108136227-B | Solubilizers for functionally active compounds | ISP投资有限公司 | 2024-12-10 | — | — | CN | claimed |
| EP-3307395-B1 | SOLUBILISING AGENTS FOR UV SCREENING COMPOUNDS | ISP INVESTMENTS LLC (US) | 2020-08-05 | — | — | EP | claimed |
| US-10328003-B2 | Solubilizing agents for active or functional organic compounds | ISP INVESTMENTS LLC (US) | 2019-06-25 | — | — | US | claimed |
| US-20180168970-A1 | SOLUBILIZING AGENTS FOR ACTIVE OR FUNCTIONAL ORGANIC COMPOUNDS | ISP INVESTMENTS LLC (US) | 2018-06-21 | — | — | US | claimed |
| EP-3307395-A1 | SOLUBILIZING AGENTS FOR FUNCTIONAL ACTIVE COMPOUNDS | ISP Investments LLC (US) | 2018-04-18 | — | — | EP | claimed |
| WO-2016201260-A1 | SOLUBILIZING AGENTS FOR FUNCTIONAL ACTIVE COMPOUNDS | ISP INVESTMENTS INC. (US) | 2016-12-15 | — | — | WO | claimed |
| CN-108136227-B | Solubilizers for functionally active compounds | ISP投资有限公司 | 2024-12-10 | — | — | CN | disclosed |
| US-20240374492-A1 | A SUNSCREEN COMPOSITION COMPRISING AVOBENZONE AND A METHOD FOR PHOTOSTABILIZATION | ISP INVESTMENTS LLC (US) | 2024-11-14 | — | — | US | disclosed |
| WO-2023009315-A1 | A SUNSCREEN COMPOSITION COMPRISING AVOBENZONE AND A METHOD FOR PHOTOSTABILIZATION | ISP INVESTMENTS LLC (US) | 2023-02-02 | — | — | WO | disclosed |
| EP-3307395-B1 | SOLUBILISING AGENTS FOR UV SCREENING COMPOUNDS | ISP INVESTMENTS LLC (US) | 2020-08-05 | — | — | EP | disclosed |
| EP-3307395-B1 | SOLUBILISING AGENTS FOR UV SCREENING COMPOUNDS | ISP INVESTMENTS LLC (US) | 2020-08-05 | — | — | EP | disclosed |
| US-10328003-B2 | Solubilizing agents for active or functional organic compounds | ISP INVESTMENTS LLC (US) | 2019-06-25 | — | — | US | disclosed |
| US-10328003-B2 | Solubilizing agents for active or functional organic compounds | ISP INVESTMENTS LLC (US) | 2019-06-25 | — | — | US | disclosed |
| US-6271321-B1 | CATALYTIC POLYMERIZATION OR COPOLYMERIZATION OF ETHYLENE AND OLEFIN MONOMERS | EASTMAN CHEMICAL COMPANY | 2001-08-07 | — | — | US | disclosed |
| WO-2001051526-A1 | PROCATALYSTS COMPRISING BIDENTATE LIGANDS, CATALYST SYSTEMS, AND USE IN OLEFIN POLYMERIZATION | EASTMAN CHEMICAL COMPANY (US) | 2001-07-19 | — | — | WO | disclosed |
| WO-2001051527-A1 | PROCATALYSTS, CATALYST SYSTEMS, AND USE IN OLEFIN POLYMERIZATION | EASTMAN CHEMICAL COMPANY (US) | 2001-07-19 | — | — | WO | disclosed |
| WO-2000075202-A1 | PROCESS FOR PRODUCING ETHYLENE/OLEFIN INTERPOLYMERS | EASTMAN CHEMICAL COMPANY (US) | 2000-12-14 | — | — | WO | disclosed |
| WO-2000075203-A1 | PROCESS FOR PRODUCING ETHYLENE/OLEFIN INTERPOLYMERS | EASTMAN CHEMICAL COMPANY (US) | 2000-12-14 | — | — | WO | disclosed |
| WO-2000075204-A1 | PROCESS FOR PRODUCING ETHYLENE/OLEFIN INTERPOLYMERS | EASTMAN CHEMICAL COMPANY (US) | 2000-12-14 | — | — | WO | disclosed |
| WO-2000052068-A1 | PROCESS FOR PRODUCING POLYETHYLENE | EASTMAN CHEMICAL COMPANY (US) | 2000-09-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10328003-B2 | Solubilizing agents for active or functional organic compounds | C1S, POLR1C, TYR | NPC1 2320/4885RAB9A 3967/4885KMT2A 4409/4885 |
| US-20180168970-A1 | SOLUBILIZING AGENTS FOR ACTIVE OR FUNCTIONAL ORGANIC COMPOUNDS | C1S, POLR1C, TYR | NPC1 2320/4885RAB9A 3967/4885KMT2A 4409/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.